Jared, age 37, started taking Risperdal in his late teens. By the time he was 21, friends started calling him “Booby Brooks” (Brooks being his surname). Needless to say, he experienced physical and psychological trauma due to gynecomastia, a Risperdal side effect. “I needed help and I’m not denying that Risperdal helped my bipolar disorder,” says Jared. “But by age 21, I started growing breasts, which are painful and very embarrassing. It wasn’t easy in my early 20s with so many stares. My close friends still call me Booby Brooks, but it is still frustrating.”
At the age of 18, Jared became a ward of the state. “That is when I made wrong choices and overdosed,” he says, adding that he is lucky to be alive. “Reality jumps in and out of my life. The meds are working right now, talking to you. When they aren’t working I hear voices and get delusional. I suffered a lot of brain damage from ages 18-24 and I’m told it is permanent psychosis.
“Most of the time I don’t know how to get help, until I switched to a different medication.” Jared was “on and off” Risperdal until 2010, when he was diagnosed with schizoaffective disorder and was prescribed Invega.
Invega (paliperidone) was FDA-approved in 2006 for treatment of acute schizophrenia. Also called the son of Risperdal, it has been found to have the same side effects as its derivative—risperidone. And both drugs are made by Johnson & Johnson. Both medications work by blocking dopamine receptors. In doing so, the production of the hormone prolactin is blocked. As prolactin levels are elevated—which are normally at very low levels in men and very high in pregnant women—gynecomastia develops. When Risperdal or Invega causes gynecomastia in men and boys, their ‘breasts’ might even begin to produce a milky white discharge.
READ MORE RISPERDAL LEGAL NEWS
“Now I’m not so embarrassed to talk about being “Booby Brooks” because I know others are suffering too and I’m not alone.”
According to a study by the New Zealand Medicines and Medical Devices Safety Authority, more than 90 percent of those taking Risperdal had elevated levels of prolactin. In clinical trials involving 1,885 children and adolescents taking Risperdal, 43 boys experienced gynecomastia. Since the FDA approved the drug for use in children, hundreds of boys have developed breasts, some with breasts as large as “D” cups, while on the medication.